Related Experiment Video
Updated: Feb 27, 2026
11:42
Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
Published on: November 4, 2019
6.6K
Forward RNAi Screens in Human Hematopoietic Stem Cells
Roman Galeev1, Christine Karlsson1, Aurélie Baudet1
1Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, BMC A12, Sölvegatan 17, 221 84, Lund, Sweden.
Methods in Molecular Biology (Clifton, N.J.)
|July 5, 2017
Summary
This study introduces a novel RNA interference (RNAi) screening method using next-generation sequencing (NGS) for human hematopoietic stem and progenitor cells (HSPCs). This approach aids in discovering genes regulating stem cell self-renewal and differentiation.
Area of Science:
- Stem cell biology
- Cancer biology
- Hematopoiesis
Background:
- Understanding somatic stem cell self-renewal and differentiation is crucial for stem cell and cancer research.
- Hematopoietic stem cells (HSPCs) are key targets for studying these regulatory mechanisms.
Purpose of the Study:
- To present a method for RNA interference (RNAi)-based screens coupled with next-generation sequencing (NGS).
- To enable the dissection of regulatory mechanisms in hematopoietic stem cells (HSCs) and other somatic stem cells.
- To identify potential gene targets for ex vivo stem cell expansion strategies.
Main Methods:
- Utilized RNA interference (RNAi) screening.
- Employed next-generation sequencing (NGS) for data analysis.
- Applied pooled lentiviral short hairpin RNA (shRNA) libraries for complex screens in primary human HSPCs.
Main Results:
- Demonstrated the feasibility of RNAi-based screens in primary human HSPCs.
- Established a method suitable for selection-based screens.
- Provided a tool for dissecting regulatory mechanisms in stem cells.
Conclusions:
- The described RNAi-NGS screening method is a powerful tool for stem cell research.
- This approach can identify novel gene targets and modifiers in hematopoietic stem cells.
- The findings may advance strategies for ex vivo stem cell expansion.
